Literature DB >> 8168960

Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates.

T E Lane1, B A Wu-Hsieh, D H Howard.   

Abstract

The mechanism by which recombinant murine gamma interferon (rMuIFN-gamma) and bacterial lipopolysaccharide (LPS) activate mouse resident splenic macrophages to inhibit the intracellular growth of the fungus Histoplasma capsulatum was examined. Growth inhibition depended on L-arginine metabolism. The growth inhibitory state normally induced by rMuIFN-gamma and LPS in resident splenic macrophages did not occur when the macrophages were cultured in the presence of NG-monomethyl-L-arginine, a competitive inhibitor of L-arginine metabolism. Resident splenic macrophages treated with rMuIFN-gamma and LPS produced nitrite (NO2-), an end product of L-arginine metabolism. When macrophages were cultured in the presence of NG-monomethyl-L-arginine together with rMuIFN-gamma and LPS, only baseline levels of NO2- were detected. Spleen cells from H. capsulatum-infected mice produced high levels of NO2- in culture. The production of NO2- correlated with in vitro inhibition of the intracellular growth of H. capsulatum. Anti-tumor necrosis factor alpha antibody did not block NO2- production by the immigrant splenic macrophages and did not abolish the antihistoplasma activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168960      PMCID: PMC186447          DOI: 10.1128/iai.62.5.1940-1945.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.

Authors:  J C Drapier; J B Hibbs
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli.

Authors:  B Bartholomew
Journal:  Food Chem Toxicol       Date:  1984-07       Impact factor: 6.023

3.  Modulation of the macrophage oxidative burst by Histoplasma capsulatum.

Authors:  J E Wolf; V Kerchberger; G S Kobayashi; J R Little
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

4.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages.

Authors:  B Wu-Hsieh; D H Howard
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Expression of the transferrin receptor on murine peritoneal macrophages is modulated by in vitro treatment with interferon gamma.

Authors:  T A Hamilton; P W Gray; D O Adams
Journal:  Cell Immunol       Date:  1984-12       Impact factor: 4.868

8.  INTRACELLULAR GROWTH OF HISTOPLASMA CAPSULATUM.

Authors:  D H HOWARD
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

9.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

10.  Properties of isolated red pulp macrophages from mouse spleen.

Authors:  A R Nusrat; S D Wright; A A Aderem; R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  14 in total

1.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

2.  Human dendritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion.

Authors:  Lucy A Gildea; Georgianne M Ciraolo; Randal E Morris; Simon L Newman
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Effect of nitric oxide donors on survival of conidia, germination and growth of Aspergillus fumigatus in vitro.

Authors:  J Kunert
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.

Authors:  Rebecca Blackstock; Juneann W Murphy
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

6.  A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages.

Authors:  Li Shi; Priscila C Albuquerque; Eszter Lazar-Molnar; Xintao Wang; Laura Santambrogio; Attila Gácser; Joshua D Nosanchuk
Journal:  Eukaryot Cell       Date:  2008-05-16

Review 7.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 8.  Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis.

Authors:  Andrew L Garfoot; Chad A Rappleye
Journal:  FEBS J       Date:  2015-11-25       Impact factor: 5.542

Review 9.  Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Authors:  Jamie Mittal; Maria G Ponce; Inessa Gendlina; Joshua D Nosanchuk
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

10.  Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection.

Authors:  Priscilla Aparecida Tartari Pereira; Bruno Caetano Trindade; Adriana Secatto; Roberto Nicolete; Camila Peres-Buzalaf; Simone Gusmão Ramos; Ruxana Sadikot; Claudia da Silva Bitencourt; Lúcia Helena Faccioli
Journal:  Mediators Inflamm       Date:  2013-04-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.